ATE334690T1 - Zusammensetzungen zur behandlung von bindegeweben,die ein eisen(ii)-ion und ascorbat enthalten - Google Patents
Zusammensetzungen zur behandlung von bindegeweben,die ein eisen(ii)-ion und ascorbat enthaltenInfo
- Publication number
- ATE334690T1 ATE334690T1 AT01927527T AT01927527T ATE334690T1 AT E334690 T1 ATE334690 T1 AT E334690T1 AT 01927527 T AT01927527 T AT 01927527T AT 01927527 T AT01927527 T AT 01927527T AT E334690 T1 ATE334690 T1 AT E334690T1
- Authority
- AT
- Austria
- Prior art keywords
- ascorbate
- treatment
- compositions
- connective tissue
- ferric ion
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 8
- 239000000203 mixture Substances 0.000 title abstract 5
- 229940072107 ascorbate Drugs 0.000 title abstract 4
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 4
- 239000011668 ascorbic acid Substances 0.000 title abstract 4
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 title 1
- 210000002808 connective tissue Anatomy 0.000 title 1
- 229910001447 ferric ion Inorganic materials 0.000 title 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 abstract 3
- 229910001448 ferrous ion Inorganic materials 0.000 abstract 3
- 201000008482 osteoarthritis Diseases 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- CBOJBBMQJBVCMW-BTVCFUMJSA-N (2r,3r,4s,5r)-2-amino-3,4,5,6-tetrahydroxyhexanal;hydrochloride Chemical compound Cl.O=C[C@H](N)[C@@H](O)[C@H](O)[C@H](O)CO CBOJBBMQJBVCMW-BTVCFUMJSA-N 0.000 abstract 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 230000022159 cartilage development Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229960002442 glucosamine Drugs 0.000 abstract 1
- 150000002301 glucosamine derivatives Chemical class 0.000 abstract 1
- 229960001911 glucosamine hydrochloride Drugs 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Removal Of Specific Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20036100P | 2000-04-28 | 2000-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE334690T1 true ATE334690T1 (de) | 2006-08-15 |
Family
ID=22741396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01927527T ATE334690T1 (de) | 2000-04-28 | 2001-04-25 | Zusammensetzungen zur behandlung von bindegeweben,die ein eisen(ii)-ion und ascorbat enthalten |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6632804B2 (de) |
| EP (1) | EP1276485B1 (de) |
| JP (1) | JP2003531858A (de) |
| AT (1) | ATE334690T1 (de) |
| AU (1) | AU2001254556A1 (de) |
| CA (1) | CA2343439C (de) |
| DE (1) | DE60121932D1 (de) |
| WO (1) | WO2001082938A2 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7851458B2 (en) * | 1999-06-22 | 2010-12-14 | Joint Juice, Inc. | Cartilage enhancing food supplements and methods of preparing the same |
| ES2190379B1 (es) * | 2001-12-21 | 2004-11-16 | Bioiberica,S.A | Procedimiento de preparacion de sales de glucosamina. |
| US7803787B2 (en) * | 2002-10-16 | 2010-09-28 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treating connective tissue damage by transmucosal administration |
| US8455458B2 (en) | 2002-10-16 | 2013-06-04 | Arthrodynamic Technologies, Animal Health Division, Inc. | Composition and method for treating connective tissue damage |
| US20080003258A1 (en) * | 2002-10-16 | 2008-01-03 | Marcum Frank D | Composition and Method for Treating Rheumatoid Arthritis |
| US20040086581A1 (en) * | 2002-11-06 | 2004-05-06 | Jones Edwin B. | Bio-energetic joint and arthritis pain formula |
| CN1232256C (zh) * | 2003-03-27 | 2005-12-21 | 中国人民解放军第三军医大学 | N－乙酰氨基葡萄糖在制备治疗自身免疫反应所致的局部损伤或全身症状的药物中的应用 |
| US8633246B2 (en) * | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Omega-3 fatty acids for osteoarthritis |
| US8633247B2 (en) * | 2003-08-11 | 2014-01-21 | Hill's Pet Nutrition, Inc. | Method for decreasing cartilage damage in dogs |
| ES2255829B1 (es) * | 2004-08-06 | 2007-08-16 | Bioiberica, S.A. | Nuevo uso de sales de glucosamina. |
| WO2006112012A1 (ja) * | 2005-04-13 | 2006-10-26 | Snow Brand Milk Products Co., Ltd. | 栄養組成物 |
| DE102005020327A1 (de) | 2005-04-30 | 2006-11-09 | Multibind Biotec Gmbh | Dekontaminationslösungen und deren Verwendung zur Denaturierung, Modifikation, Degradation, Solubilisierung und Entfernung von Proteinen, Nukleinsäuremolekülen und Mikroorganismen von Oberflächen |
| DE102006001213A1 (de) * | 2006-01-10 | 2007-07-12 | Multibind Biotec Gmbh | Synergistische Lösung aus Ascobinsäure oder deren Derivaten und Metallionen effizienten, selektiven Abtötung pathologischer Säugerzellen |
| WO2007143660A1 (en) * | 2006-06-05 | 2007-12-13 | Stokely-Van Camp, Inc. | Reducing muscle soreness with glucosamine compositions |
| US9186375B2 (en) | 2007-06-21 | 2015-11-17 | Arthrodynamic Technologies, Animal Health Division, Inc. | Glycosaminoglycan compositions in combination with stem cells |
| BE1019135A5 (nl) * | 2010-01-08 | 2012-03-06 | Lab Smeets Nv | Voedingssupplement bevattende glucosamine. |
| WO2014138407A1 (en) * | 2013-03-06 | 2014-09-12 | Rutgers, The State University Of New Jersey | Nutritional supplement/feed formula and methods of use thereof to reduce development of osteochondrosis dissecans (ocd) lesions |
| EP2886104A1 (de) | 2013-12-11 | 2015-06-24 | Patir, Suleyman | Intraartikuläres Gel |
| US20190021995A1 (en) * | 2015-12-30 | 2019-01-24 | Alexander Vilenovich ASAFOV | Formulation for treatment of peripheral joints, spinal joints and/or extracellular matrix elements of connective tissue, method of manufacture and uses |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2822317A (en) * | 1955-12-12 | 1958-02-04 | Smith Kline French Lab | Aqueous iron-ascorbic acid preparation |
| IT1044707B (it) | 1968-10-26 | 1980-04-21 | Rotta Research Lab | Procedimento per la preparazione di sali di glucosanina e preparati farmaceutici comprendenti detti sali di glucosamina come agenti attivi |
| NZ194947A (en) | 1979-09-18 | 1983-06-14 | C Holland | Composition containing calcium and ferrous ions for treatment of rheumatoid arthritis |
| WO1985000033A1 (fr) * | 1983-06-18 | 1985-01-03 | Japan As Represented By Director-General Of Agency | Solution aqueuse chimiquement active et substance solide contenant des ions ferreux |
| US5405613A (en) * | 1991-12-11 | 1995-04-11 | Creative Nutrition Canada Corp. | Vitamin/mineral composition |
| US5364845C1 (en) | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
| AT408416B (de) * | 1996-07-19 | 2001-11-26 | Norbert Fuchs | Pharmazeutische bzw. diätetische zusammensetzungen |
| GB2317109B (en) | 1996-08-28 | 2000-06-21 | Farmsense | A therapeutic composition for the treatment and repair of connective tissue in mammals |
| GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
| US6245360B1 (en) * | 1998-06-26 | 2001-06-12 | John S. Markowitz | Nutritional supplement |
| US6177476B1 (en) * | 1998-08-27 | 2001-01-23 | Clarion Pharmaceuticals Inc. | Nutritional supplements for replenishing plasmalogens |
| DE20004010U1 (de) * | 2000-03-02 | 2000-06-21 | Febena Pharma GmbH, 50825 Köln | Diätische Zusammensetzung mit einem Gehalt an Glycosaminoglycanen |
-
2001
- 2001-04-25 DE DE60121932T patent/DE60121932D1/de not_active Expired - Lifetime
- 2001-04-25 AU AU2001254556A patent/AU2001254556A1/en not_active Abandoned
- 2001-04-25 US US09/842,742 patent/US6632804B2/en not_active Expired - Fee Related
- 2001-04-25 EP EP01927527A patent/EP1276485B1/de not_active Expired - Lifetime
- 2001-04-25 WO PCT/CA2001/000564 patent/WO2001082938A2/en not_active Ceased
- 2001-04-25 JP JP2001579812A patent/JP2003531858A/ja active Pending
- 2001-04-25 AT AT01927527T patent/ATE334690T1/de not_active IP Right Cessation
- 2001-04-25 CA CA002343439A patent/CA2343439C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1276485A2 (de) | 2003-01-22 |
| CA2343439A1 (en) | 2001-07-09 |
| CA2343439C (en) | 2003-06-24 |
| DE60121932D1 (de) | 2006-09-14 |
| AU2001254556A1 (en) | 2001-11-12 |
| EP1276485B1 (de) | 2006-08-02 |
| US20010044425A1 (en) | 2001-11-22 |
| WO2001082938A2 (en) | 2001-11-08 |
| JP2003531858A (ja) | 2003-10-28 |
| US6632804B2 (en) | 2003-10-14 |
| WO2001082938A3 (en) | 2002-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE334690T1 (de) | Zusammensetzungen zur behandlung von bindegeweben,die ein eisen(ii)-ion und ascorbat enthalten | |
| IS6852A (is) | Efnasambönd | |
| BR0109165A (pt) | Método de tratamento de pólipos colÈnicos | |
| ATE443043T1 (de) | Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer | |
| PL406680A1 (pl) | Inhibitory kinaz tyrozynowych | |
| MY148632A (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| GEP20032869B (en) | Alpha -Ketoamide Inhibitors of 20S Proteasome, Pharmaceutical Preparations Containing the Same and Methods for Treatment | |
| UA89040C2 (ru) | Замещенные глюкопиранозилом бензольные производные, лекарственное средство, которое содержит эти соединения | |
| ATE412646T1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| ATE442141T1 (de) | Verfahren zur behandlung von stoffwechselerkrankungen mit malonyl-coa- decarboxylase-hemmern | |
| DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit | |
| SI1648484T1 (sl) | Farmacevtske oblike za zdravljenje artritiäśnih stanj | |
| MXPA04006255A (es) | Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato. | |
| WO2003106384A3 (en) | Novel boronic chalcone derivatives and uses thereof | |
| ATE516027T1 (de) | Orazamid orotat zur vorbeugung von leberschäden | |
| BR0212535A (pt) | Compostos e composições como inibidores de catepsina | |
| TNSN08057A1 (en) | Combinations comprising dmxaa for the treatment of cancer | |
| GEP20053590B (en) | Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors | |
| EA200600992A1 (ru) | Амиды тиазолидинона, амиды тиазолидинкарбоновой кислоты, способы их получения и их применение | |
| BR0312470A (pt) | Composto, uso do mesmo, composição farmacêutica, método de tratar e/ou prevenir câncer, e, processo para preparar o composto | |
| TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
| ATE274513T1 (de) | Verbindungen und verfahren zur behandlung von schmerz | |
| DE60131968D1 (de) | PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN | |
| ATE279918T1 (de) | Verwendung von aloe-emodin zur behandlung von neuroektodermalen tumoren | |
| CY1108980T1 (el) | Χρηση πολυσουλφωμενων κυκλοδεξτρινων για τη θεραπεια της αρθριτιδας |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |